Steve Weldon Letter of Resignation, dated November 11, 2020
EX-10.21 4 gtbp_ex1021.htm STEVE WELDON LETTER OF RESIGNATION gtbp_ex1021
November 11, 2020
GT Biopharma Inc.
9350 Wilshire Blvd., Suite 203
Beverly Hills, CA 990212
This letter is my notice of resignation as the Chief Financial Officer and Director of GT Biopharma, Inc. effective immediately.
/s/ Steven Weldon
Steven Weldon, MBA, CPA